Accès ouvert
2023
article
OpenAlex
Olga Horakova, Gabriella Sistilli, Veronika Kalendová, Kristina Bardová et autres
Introduction Non-alcoholic fatty liver disease (NAFLD) can progress to more severe stages, such as steatohepatitis and fibrosis. Thermoneutral housing together with high-fat diet promoted NAFLD progression in C57BL/6J mice. Due to possible differences in steatohepatitis development between different C57BL/6 substrains, we examined …
cz, at
(code pays fourni par la source)
2023
article
OpenAlex
Martin Rossmeisl, Veronika Kalendová, Olga Horakova
2023
article
OpenAlex
Olga Horakova, Gabriella Sistilli, Veronika Kalendová, Tomáš Čajka et autres
Accès ouvert
2021
article
OpenAlex
Gabriella Sistilli, Veronika Kalendová, Tomáš Čajka, Illaria Irodenko et autres
Preclinical evidence suggests that n-3 fatty acids EPA and DHA (Omega-3) supplemented as phospholipids (PLs) may be more effective than triacylglycerols (TAGs) in reducing hepatic steatosis. To further test the ability of Omega-3 PLs to alleviate liver steatosis, we used a model …
cz, at, it
(code pays fourni par la source)
2020
article
OpenAlex
Martin Rossmeisl, Jana Pavlišová, Kristina Bardová, Veronika Kalendová et autres
cz
(code pays fourni par la source)
2020
article
OpenAlex
Jana Pavlišová, Olga Horakova, Veronika Kalendová, Jana Buresova et autres
n-3 polyunsaturated fatty acids (PUFA) can exert beneficial effects on glucose homeostasis, especially in obese rodents. Gut incretin hormones regulate glucose and lipid homeostasis, but their involvement in the above effects is not entirely clear. This study aims to assess the effects …
cz, us
(code pays fourni par la source)
2017
dissertation
OpenAlex
Veronika Kalendová
2017
dissertation
OpenAlex
Veronika Kalendová
Obesity is tightly connected with metabolic diseases including insulin resistance, type 2 diabetes or dyslipidemia. Peroxisome proliferator-activated receptor (PPAR)-α is a key transcription factor involved in the regulation of lipid metabolism, while its activity is stimulated by a variety of hypolipidemic drugs. …
2016
conference-abstract
OpenAlex
Martin Rossmeisl, Jana Pavlišová, Petra Kuchaříková, Veronika Kalendová et autres
2015
dissertation
OpenAlex
Veronika Kalendová
2015
dissertation
OpenAlex
Veronika Kalendová
Obesity is associated with metabolic complications including insulin resistance, dyslipidemia and hypertension (metabolic syndrome). The endocannabinoid system (ECS) activity is elevated in obesity, which can further potentiate metabolic impairments. Pharmacological treatment based on the cannabinoid receptor CB1 blockade led to a decrease …